Fundz

Eiger Biopharmaceuticals Inc reported raising $6 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATENov 20, 2015

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Nov 20, 2015)

Round Type

Venture

CaliforniaBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as EIGER BIOPHARMACEUTICALS INC that raised within 45 days of this round, from Fundz verified event records.

  • Scholar Rock raised $36M on January 4, 2016.
  • Efferent Labs, Inc. raised an undisclosed amount on January 4, 2016.
  • Mellitus, LLC raised $50K (Seed) on January 4, 2016.
  • Agenus raised $7.4M on January 4, 2016.
  • Parsagen Diagnostics, Inc. raised $595K (Seed) on January 4, 2016.
  • Endovia Health Sciences, Inc. raised an undisclosed amount on January 4, 2016.

Who to call at EIGER BIOPHARMACEUTICALS INC, and when

A new round usually means EIGER BIOPHARMACEUTICALS INC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EIGER BIOPHARMACEUTICALS INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EIGER BIOPHARMACEUTICALS INC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EIGER BIOPHARMACEUTICALS INC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EIGER BIOPHARMACEUTICALS INC

Location

California, United States

About

Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EIGER BIOPHARMACEUTICALS INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAshwini, Head of CMCSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for EIGER BIOPHARMACEUTICALS INC's next move

See what Strategic adds

EIGER BIOPHARMACEUTICALS INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.